YOUR HEALTH. A MORE INFORMED VIEW.

Ultimate Sexual
Wellness.

Genital and urinary targets in one wider panel.

AED 1,499per package · collection included
Call us
Dr Nirupama SabhapathyCLINICAL AUTHORDr Nirupama SabhapathySpecialist Clinical Pathology
adult couple in a discreet consultation with an Intel Lab folder.
57Analytes
in one package
Intel LabCollected around you.
Understood in context.
Included
57 Analytes57 named target entries · 2 included assays · 57 Analytes
Samples
UrinePreparation tailored to the sample
Results
48 hoursListed laboratory turnaround
Collection
IncludedArrange with the care team

THE PURPOSE BEHIND THE PANEL.

Choose the scope.
Understand the result.

The combined package brings together the STD-28 panel and a urinary-organism/resistance panel. Overlapping organisms and gene targets mean the headline count and component totals use different units.

Named organism targets — conceptual laboratory artwork45named targets

45 listed entries

Exact source inventory

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

What this means in context

Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.

KNOW EXACTLY WHAT YOU ARE CHOOSING.

57 Analytes.
The scope, made clear.

The published inventory contains 57 analytes: 45 named organism targets and 12 selected resistance genes. The two component panels overlap, so adding their separate counts would duplicate some entries. A gene is not a separate infection or a complete susceptibility result.

57Analytes
57named target entries2 included assays
UrineListed specimen type

57 named target entries · 2 included assays · 57 Analytes

Browse by group. Search to find a named target.

Named organism targets

45 entries
Chlamydia trachomatis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Neisseria gonorrhoeae

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Varicella Zoster Virus

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Cytomegalovirus

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Lymphogranuloma Venereum

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida glabrata

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida krusei

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida lusitaniae

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida parapsilosis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida tropicalis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida dubliniensis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Atopobium vaginae

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Bacterial vaginosis-associated bacteria 2 (BVAB-2)

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Lactobacillus spp.

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Megasphaera type 1

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Mobiluncus spp.

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Trichomonas vaginalis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Mycoplasma hominis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Mycoplasma genitalium

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Herpes simplex virus type 1

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Herpes simplex virus type 2

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Treponema pallidum

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Haemophilus ducreyi

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Candida albicans

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Gardnerella vaginalis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Acinetobacter baumannii

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Staphylococcus aureus

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Klebsiella pneumoniae

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Morganella morganii

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Staphylococcus saprophyticus

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Pseudomonas aeruginosa

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Enterococcus faecium

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Streptococcus agalactiae

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Enterococcus faecalis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Ureaplasma urealyticum

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Serratia marcescens

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Proteus mirabilis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Escherichia coli

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Klebsiella oxytoca

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Ureaplasma parvum

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Klebsiella aerogenes

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Enterobacter cloacae

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Bacteroides fragilis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Staphylococcus epidermidis

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Citrobacter spp.

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Resistance markers

12 entries
blaKPC

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

blaNDM

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

blaOXA-48

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

blaVIM

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

blaIMP

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

CTX-M

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

mecA

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

vanA

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

vanB

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

sul1

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

sul2

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

sul3

This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.

Included laboratory assays

2 entries
UTI & Drug Resistance Gene PanelExplore the named components

Looks for listed urinary organisms and selected resistance genes. Gene detection is not a full antibiotic-susceptibility result or a treatment prescription.

INCLUDED COMPONENTS

Yeast

  • Candida albicansCA

Gram-negative bacteria

  • Acinetobacter baumannii
  • Klebsiella pneumoniae
  • Morganella morganii
  • Pseudomonas aeruginosa
  • Serratia marcescens
  • Proteus mirabilis
  • Escherichia coli
  • Klebsiella oxytoca
  • Klebsiella aerogenes
  • Enterobacter cloacae
  • Bacteroides fragilis
  • Citrobacter spp.

Gram-positive bacteria

  • Staphylococcus aureus
  • Staphylococcus saprophyticus
  • Enterococcus faecium
  • Streptococcus agalactiae
  • Enterococcus faecalis
  • Staphylococcus epidermidis

Carbapenem resistance (carbapenemases)

  • blaKPC
  • blaNDM
  • blaVIM
  • blaIMP
  • blaOXA-48

Other beta-lactam resistance (ESBL, MRSA)

  • mecA
  • CTX-M

Vancomycin resistance

  • vanA
  • vanB

Sulfonamide resistance

  • suL1
  • suL2
  • suL3
Read the test guide
STI-28 Panel PCRExplore the named components

Looks for twenty-eight listed sexually transmitted and genital-flora targets. Not every target is an STI or requires treatment when detected.

INCLUDED COMPONENTS

Sexually transmitted infections

  • Chlamydia trachomatisCT
  • Neisseria gonorrhoeaeNG
  • Trichomonas vaginalisTV
  • Mycoplasma genitaliumMG
  • Treponema pallidumTP
  • Haemophilus ducreyiHD
  • Lymphogranuloma venereumLGV

Genital mycoplasmas and ureaplasmas

  • Mycoplasma hominisMH
  • Ureaplasma urealyticumUU
  • Ureaplasma parvumUP

Viruses

  • Herpes simplex virus type 1HSV-1
  • Herpes simplex virus type 2HSV-2
  • CytomegalovirusCMV
  • Varicella zoster virusVZV

Candida species

  • Candida albicansCA
  • Candida tropicalisCTP
  • Candida kruseiCKR
  • Candida glabrataCG
  • Candida parapsilosisCP
  • Candida lusitaniaeCL
  • Candida dubliniensisCD

Genital flora and bacterial vaginosis

  • Gardnerella vaginalisGV
  • Bacterial vaginosis-associated bacteria 2BVAB-2
  • Lactobacillus spp.LBS
  • Mobiluncus spp.MBS
  • Megasphaera type 1MP-1
  • Atopobium vaginaeAV
  • Bacteroides fragilisBF
Read the test guide

Checking a prescription?
Let’s make sure it matches.

THE RIGHT START DEPENDS ON YOU.

A useful package.
A personal decision.

Choose the investigation around the question you want to discuss. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.

01

A defined question

The combined package brings together the STD-28 panel and a urinary-organism/resistance panel. Overlapping organisms and gene targets mean the headline count and component totals use different units.

02

Matching a prescription

Compare the full included list with your clinician’s request. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.

03

Following a previous finding

Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.

MAKE THE SAMPLE COUNT.

A little preparation.
A more useful result.

Preparation follows the actual specimen and tests in Ultimate Sexual Wellness. Confirm your personal instructions before collection.

Intel Lab specimen collection kit
01
Urine.One coordinated pathway.
YOUR PREPARATION0 of 4 ready

A personal checklist. Your care team confirms the instructions.

YOUR COLLECTION. YOUR CHOICE.

Care comes to you.
Or visit your laboratory.

Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.

YOUR PLACE. THE SAME LABORATORY PATHWAY.

A familiar setting.
A professional collection.

Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.

  • Collection fee included for this package’s visit
  • Choose the person and location in the shared checkout
  • Need another time? Request the earliest available appointment
Dubai coverage mapAcross Dubai

FROM BOOKING TO UNDERSTANDING.

One connected journey.
Four clear steps.

Follow Ultimate Sexual Wellness from your care bag to an informed conversation.

The right package. The right person.

Choose & assign

Add Ultimate Sexual Wellness to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.

MORE THAN A LIST OF NUMBERS.

Read the result.
Understand the context.

Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.

Explore Intel Lab Smart Report
Intel LabUNDERSTANDING YOUR REPORT

Urine

Named organism targets

The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.

Laboratory informationClinical interpretation

RESULT + CONTEXT

Exact source inventory

This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.

Questions to take to your clinician
  • What does this part of my result add to the clinical question?
  • Does the sample timing or a medicine affect this finding?
  • What follow-up is appropriate for this specific result?

THE NEXT STEP IS PERSONAL.

Bring the findings
back to you.

Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.

clinician and adult patient discussing laboratory results
01

Separate organism detection from treatment selection

Review urinary organisms and any resistance-gene findings with symptoms and the specimen context. Selected genes are not a complete susceptibility result; the clinician may request culture or other follow-up before treatment decisions.

02

Agree the next step

Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.

Explore a doctor consultation

THE LABORATORY BEHIND YOUR RESULTS.

Care in the process.
People behind the result.

Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.

Intel Lab
1M+biomarkers reported annually
25+years in medicine · Dr Nirupama
Identify and protect the sample

Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.

Analyse with quality controls

The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.

Review before the report is released

Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.

Explore laboratory quality and accreditation

EXPERTISE WITH A NAME.

Clinical minds.
Connected to your care.

Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.

Dr Nirupama Sabhapathy

Clinical author

Dr Nirupama Sabhapathy

Laboratory Director · Intel Lab

Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.

Dr Joyce Jose

Clinical reviewer

Dr Joyce Jose

Specialist Clinical Pathology · Intel Lab

Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.

CHOOSE BY PURPOSE, NOT JUST COUNT.

Explore the options.
Find the right fit.

Related packages may ask different questions. Compare their actual scope and discuss which, if any, is appropriate for you.

adult couple in a discreet consultation with an Intel Lab folder.You are viewing

Ultimate Sexual Wellness

A combined urine PCR package covering 45 named organism targets and 12 selected antibiotic-resistance genes, with clinician-led interpretation.

Analytes
57
Samples
Urine
Listed turnaround
48 hours
AED 1,499
Discreet graphite specimen pouch and Intel Lab envelope on white linen.

STD Basic Screening

A confidential 5-in-1 blood screen for the core blood-borne STIs: HIV (1 & 2), hepatitis B, hepatitis C and syphilis.

Infections
5
Samples
Blood
Listed turnaround
24 hours
AED 299
Explore package
Intel Lab precision pipette above a clear laboratory assay plate.

STD Advanced 20

A 20-marker combined work-up pairing blood serology (HIV, hepatitis B & C, syphilis) with a 14-target genital PCR panel and urinalysis: a complete…

Markers
20
Samples
Blood + Urine
Listed turnaround
48 hours
AED 699
Explore package
close view of a molecular laboratory instrument with precision pipette tips and Intel Lab branding.

STD Master 28

Our most comprehensive 28-target STI and genital-flora PCR panel, adding candida species, bacterial-vaginosis organisms and additional viruses on top…

Pathogens
28
Samples
Urine or swab
Listed turnaround
48 hours
AED 999
Explore package

Choosing for a particular need?
We can help you read the options.

BEFORE YOU BOOK.

A little more
clarity.

Preparation, sample types, timing and what the package does—and does not—include.

What is included in Ultimate Sexual Wellness?

Genital and urinary targets in one wider panel. The full named inventory on this page is the scope of the package.

Can the resistance result tell me exactly which antibiotic to take?

No. A detected gene needs organism and clinical context. Culture or other testing may be required; treatment selection belongs with the clinician.

Does molecular detection prove a symptomatic UTI?

Not by itself. Symptoms, the specimen, the organism and other findings determine clinical relevance.

Are resistance genes the same as a full susceptibility test?

No. The listed genes are selected molecular markers. Their presence or absence does not describe susceptibility to every antibiotic.

Can a urine panel assess every genital exposure site?

No. The clinical question and exposure site may require an additional or different specimen.

How should I prepare?

Use the labelled sterile container and confirm handling, collection and transport timing. Tell the team if collection instructions could not be followed.

Can I arrange collection in Dubai?

Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.

What is the price and expected turnaround?

The package price is AED 1499; the listed turnaround is 48 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.

What happens after I receive the result?

Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.

YOUR NEXT STEP. AROUND YOU.

A clearer question.
A more informed next step.

Ultimate Sexual Wellness · 57 Analytes · Urine

AED 1,499collection included for this package’s visit
Sources & further reading